Henry Schein (NASDAQ:HSIC) Stock Rating Upgraded by Evercore ISI

Key Points

• Henry Schein (NASDAQ:HSIC) was upgraded by Evercore ISI to an outperform rating with a target price of $83.00, indicating a potential upside of 21.22% from its previous close.
• Despite the upgrade, other analysts have lowered their price targets, with Barrington Research setting it to $78.00 and Piper Sandler dropping to $77.00, reflecting mixed sentiments among investment firms.
• The company reported $1.10 EPS for the last quarter, missing expectations, while its revenue grew 3.3% year-over-year, showcasing slight financial struggles.

Evercore ISI upgraded shares of Henry Schein (NASDAQ:HSIC - Free Report) from an in-line rating to an outperform rating in a report published on Tuesday morning, Marketbeat Ratings reports. The brokerage currently has $83.00 target price on the stock.

Several other research firms have also commented on HSIC. Stifel Nicolaus restated a "hold" rating and issued a $75.00 price objective (down from $80.00) on shares of Henry Schein in a research note on Friday, July 25th. Piper Sandler reduced their price objective on Henry Schein from $83.00 to $77.00 and set an "overweight" rating for the company in a research note on Wednesday, April 30th. JPMorgan Chase & Co. reduced their price objective on Henry Schein from $80.00 to $76.00 and set an "overweight" rating for the company in a research note on Thursday, August 7th. Leerink Partners set a $75.00 price objective on Henry Schein in a research note on Monday, July 14th. Finally, Robert W. Baird reiterated a "neutral" rating and issued a $72.00 price target (down previously from $82.00) on shares of Henry Schein in a research note on Monday, July 14th. Five investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of "Hold" and an average price target of $76.67.

Henry Schein Stock Performance

Shares of NASDAQ HSIC traded up $0.55 during midday trading on Tuesday, hitting $69.58. 1,021,767 shares of the stock traded hands, compared to its average volume of 2,115,911. The firm has a 50-day moving average of $70.35 and a two-hundred day moving average of $70.04. The firm has a market capitalization of $8.44 billion, a P/E ratio of 22.45, a PEG ratio of 2.30 and a beta of 0.81. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.78 and a current ratio of 1.41. Henry Schein has a one year low of $60.56 and a one year high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $1.10 EPS for the quarter, missing the consensus estimate of $1.19 by ($0.09). The company had revenue of $3.24 billion during the quarter, compared to analysts' expectations of $3.22 billion. Henry Schein had a return on equity of 14.36% and a net margin of 3.05%.The company's revenue for the quarter was up 3.3% on a year-over-year basis. During the same quarter last year, the company earned $1.23 earnings per share. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. On average, equities analysts forecast that Henry Schein will post 4.74 EPS for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Farther Finance Advisors LLC boosted its holdings in shares of Henry Schein by 237.3% during the 1st quarter. Farther Finance Advisors LLC now owns 2,698 shares of the company's stock valued at $186,000 after purchasing an additional 1,898 shares during the last quarter. State of Alaska Department of Revenue boosted its holdings in shares of Henry Schein by 2.8% during the 1st quarter. State of Alaska Department of Revenue now owns 14,611 shares of the company's stock valued at $1,000,000 after purchasing an additional 395 shares during the last quarter. Oppenheimer Asset Management Inc. boosted its holdings in shares of Henry Schein by 5.2% during the 1st quarter. Oppenheimer Asset Management Inc. now owns 13,745 shares of the company's stock valued at $941,000 after purchasing an additional 678 shares during the last quarter. GAMMA Investing LLC boosted its holdings in shares of Henry Schein by 37.8% during the 1st quarter. GAMMA Investing LLC now owns 3,939 shares of the company's stock valued at $270,000 after purchasing an additional 1,081 shares during the last quarter. Finally, Zuckerman Investment Group LLC boosted its holdings in shares of Henry Schein by 69.6% during the 1st quarter. Zuckerman Investment Group LLC now owns 201,639 shares of the company's stock valued at $13,810,000 after purchasing an additional 82,779 shares during the last quarter. Institutional investors own 96.62% of the company's stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.